An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy
Clinical trial NCT00686088 · COMPLETED
Trial details
- NCT number
- NCT00686088
- Sponsor
- Sophiris Bio Corp
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.